Active Ingredient History
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Antimetabolites (Phase 2)
Antineoplastic Agents (Phase 2)
Biliary Tract Neoplasms (Phase 1/Phase 2)
Carcinoma (Phase 2)
Carcinoma, Hepatocellular (Phase 4)
Carcinoma, Non-Small-Cell Lung (Phase 1)
Colorectal Neoplasms (Phase 3)
Digestive System Neoplasms (Phase 2)
Drugs, Investigational (Phase 2)
Esophageal Neoplasms (Phase 1/Phase 2)
Fluorouracil (Phase 2)
Healthy Volunteers (Phase 1)
Intestinal Neoplasms (Phase 1/Phase 2)
Leukemia, Myeloid, Acute (Phase 1)
Liver Neoplasms (Phase 2)
Nasopharyngeal Carcinoma (Phase 1)
Neoplasms (Phase 1/Phase 2)
Oxaliplatin (Phase 2)
Pancreatic Neoplasms (Phase 2)
Stomach Neoplasms (Phase 1/Phase 2)
Thyroid Neoplasms (Phase 3)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue